Ironwood Pharmaceuticals (IRWD) Reports In-Line Q2 Loss
Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q2 loss of ($0.19), in-line with the analyst estimate of ($0.19). Revenue for the quarter came in at $11.26 million versus the consensus estimate of $10.83 million.